US20020038145A1 - Intravascular stent with increasing coating retaining capacity - Google Patents

Intravascular stent with increasing coating retaining capacity Download PDF

Info

Publication number
US20020038145A1
US20020038145A1 US09/874,349 US87434901A US2002038145A1 US 20020038145 A1 US20020038145 A1 US 20020038145A1 US 87434901 A US87434901 A US 87434901A US 2002038145 A1 US2002038145 A1 US 2002038145A1
Authority
US
United States
Prior art keywords
stent
micro
outer surface
portion
tubular structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/874,349
Other versions
US6783543B2 (en
US20040148012A9 (en
Inventor
G. Jang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jang G David
Original Assignee
Jang G. David
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US20925500P priority Critical
Priority to US23516400P priority
Application filed by Jang G. David filed Critical Jang G. David
Priority to US09/874,349 priority patent/US6783543B2/en
Publication of US20020038145A1 publication Critical patent/US20020038145A1/en
Priority claimed from US10/374,774 external-priority patent/US20040106985A1/en
Publication of US20040148012A9 publication Critical patent/US20040148012A9/en
Application granted granted Critical
Publication of US6783543B2 publication Critical patent/US6783543B2/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T83/00Cutting
    • Y10T83/04Processes

Abstract

An expandable stent includes a tubular structure with an outer surface positionable adjacent to a vessel wall and an inner surface facing a lumen of a body passageway. The tubular structure further includes a plurality of expansion struts, connector struts and cells. The tubular structure has a first diameter which permits intraluminal delivery of the tubular structure into the body passageway, and a second expanded and deformed diameter which is achieved upon the application of a radially, outwardly extending force. A plurality of cavities are formed in the outer surface of the stent.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of Provisional Patent Application No.: 60/235,164 filed Sep. 23, 2000, the disclosure of which is incorporated by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of Invention [0002]
  • This invention relates generally to intravascular stents, and more particularly to intravascular stents that include a plurality of cavities formed on a surface of the stent and are coated with a restenosis inhibiting agent. [0003]
  • 2. Description of the Related Art [0004]
  • By 1999, the percutaneous balloon angioplasty and stent implant procedures have become the dominant non-surgical revascularization method of the atherosclerotic stenosis, or obstruction, of the vascular lumen, and particularly in the coronary vascular system in the heart. With balloon angioplasty alone, without use of stent, the restenosis rate after angioplasty has been as high as 25-45% in the first time clinical cases. With use of stents after balloon angioplasty, the restenosis has been reduced significantly. Even so, the restenosis rate after stent implant is reported as 10-25% range depending on the condition of the vessel stented or what specific stent was used, requiring a need for further restenosis reducing measures after intravascular stenting. [0005]
  • To further reduce the restenosis rate after stent implant, numerous means has been tried, including laser, atherectomy, high frequency ultrasound, radiation device, local drug delivery, etc. Although the brachytherapy (radiation treatment) has proved to be reasonably effective in further reducing restenosis after stent implant, using brachytherpy is very cumbersome, inconvenient and costly. Mainly because it is radioactive device and radiation therapy specialist from another department has to be involved with the interventional cardiologist in the cardiac catheterization laboratory. The laser and atherectomy devices proved to be marginally useful in this purpose with added costs. [0006]
  • The local drug therapy appears be a very promising method for the future, as better pharmaceutical, chemical or biogenetic agents are developed and became available. Some research data, both from animal tests and human clinical studies, indicate that there are evidences of suppressing restenosis after stent implant when certain growth blocking pharmaceutical agents available today are used to coat the stent. In another instances, it has been speculated that certain surface modifying materials coated on the surface of the stent may be beneficial by it alone or in combination with growth suppressing agent, in reducing restenosis rate. In either instance, the drug or substance should be locally attached or coated on the stent and in sufficient amounts. However, attaching or coating a sufficient amount of a substance or drug on the coronary stent is not so easy a proposition. [0007]
  • Coating a drug or an agent on the surface of the stent has a demanding problem of enough volume of such substance coated on the small surface areas of stent struts, without increasing the physical width or thickness of stent struts. This demand directly conflicts with the metal fraction issue of the stent. If the width (and lesser degree the thickness) of stent struts is increased in order to widen drug coating surface areas, it would have an elevated deleterious foreign body effect of the increased metal fraction of the stent, which would promote restenosis. [0008]
  • Designing an ideal stent, particularly the coronary stent, is a very demanding balance of a numerous conflicting factors. An ideal stent requires an ideal balance of numerous different stent features built into the stent. One of the many requirements of a coronary, or any vascular stent, is to keep the metal fraction of the stent low. This means that drug coating is a very demanding task. Enough amounts of a drug or agent should be coated on the miniscule surface areas of the stent struts, in order to have the desired drug results of reducing restenosis. An average stent, particularly a coronary stent, will have problem of providing desired amount of drug-retaining capacity on the surface areas of the stent struts. [0009]
  • The main invention of this application is not an invention of the stent itself. The present invention is the particular measures designed to increase drug coating or attachment capacity of a stent by adding exposed surface areas or reservoir capacity of the stent, without increasing the width or thickness of the stent struts or without increasing the metal fraction of the stent. These special measures of present invention will enhance the coating substances to a stent. Further, the present invention will enhance the reservoir capacity of the stent for different forms of restenosis reducing proteins, chemicals or drugs, and will prolong the releasing time duration of the substances. [0010]
  • U.S. Pat. No. 6,190,404 discloses an intravascular stent with an outer surface, an inner surface and grooves formed in the inner surface of the stent. The grooves are positioned and provided to increase the rate of migration of endothelial cells upon the inner surface of the stent. [0011]
  • There is a need for a stent with a geometry that provides for an increased amount of a coating substance. There is a further need for a stent that includes reservoirs for retaining coatings. [0012]
  • SUMMARY OF THE INVENTION
  • Accordingly, an object of the present invention is to provide an intravascular stent with a geometry that provides for an increased amount of a coating substance. Another object of the present invention is to provide an intravascular stent with cavities formed in the stent that serve as reservoirs of coatings applied to the stent. Yet another object of the present invention is to provide an intravascular stent with cavities formed in the body of the stent and with a restenosis inhibiting agent applied to the stent. [0013]
  • Another object of the present invention is to provide an intravascular stent with micro-holes or micro-slits that provide reservoirs for stent coatings. These and other objects of the present invention are achieved in an expandable stent. A tubular structure includes an outer surface positionable adjacent to a vessel wall and an inner surface facing a lumen of a body passageway. The tubular structure further includes a plurality of expansion struts, connector struts and cells. The tubular structure has a first diameter which permits intraluminal delivery of the tubular structure into the body passageway, and a second expanded and deformed diameter which is achieved upon the application of a radially, outwardly extending force. A plurality of cavities are formed in the outer surface of the stent. [0014]
  • In another embodiment of the present invention, an expandable stent, includes a tubular structure with an outer surface positionable adjacent to a vessel wall, an inner surface facing a lumen of a body passageway, a plurality of expansion struts, connector struts and cells. The tubular structure has a first diameter which permits intraluminal delivery of the tubular structure into the body passageway, and a second expanded and deformed diameter that is achieved upon the application of a radially, outwardly extending force. A plurality of cavities formed in the outer surface of the stent. A coating substance is on at least a portion of outer surface of the stent including and extends into at least a portion of the cavities. [0015]
  • In another embodiment of the present invention, a stent assembly includes a balloon and an expandable stent positioned at an exterior of the balloon. The stent includes a tubular structure with an outer surface positionable adjacent to a vessel wall, an inner surface facing a lumen of a body passageway, a plurality of expansion struts, connector struts and cells. The tubular structure has a first diameter which permits intraluminal delivery of the tubular structure into the body passageway, and a second expanded and deformed diameter that is achieved upon the application of a radially, outwardly extending force applied by the balloon. A plurality of cavities are formed in the outer surface of the stent. A coating substance is on at least a portion of outer surface of the stent including and extending into at least a portion of the cavities. [0016]
  • In another embodiment of the present invention, a method of manufacturing an intravascular stent is provided. The intravascular stent has an inner surface and an outer surface. A plurality of cavities are formed on the outer surface. A coating substance that inhibits restenosis is formed on at least a portion of the outer surface and on at least a portion of the plurality of cavities[0017]
  • BRIEF DESCRIPTION OF DRAWINGS
  • FIG. 1 is a flat cut-open, two-dimensional, schematic view of one embodiment of a stent of the present invention that includes cavities formed in the body of the stent. [0018]
  • FIG. 2 is a close-up view of the stent from FIG. 1 with cavities that extend from the outer surface of the stent into an interior of the stent. [0019]
  • FIG. 3 is a cross-section, side view of a stent of the present invention with cavities that extend from the outer surface through the inner surface. [0020]
  • FIG. 3([0021] b) is a cross-sectional, magnified, side view of one embodiment of the stent of the present invention illustrating that cavities can be closed and serve as reservoirs for coating substance applied to the stent.
  • FIG. 3([0022] c) is a cross-sectional, magnified view of another embodiment of the present invention illustrating a stent that includes cavities that extent at a slant angle from the outer surface through the inner surface.
  • FIG. 3([0023] d) is a cross-sectional, magnified, side view of one embodiment of the present invention with cavities that extend at a slant, non-perpendicular angle from the outer surface to an interior of the stent.
  • FIG. 4 is a flat cut-open, two-dimensional, schematic view of a stent seen from the outer surface of the stent cavities distributed in an even pattern [0024]
  • FIG. 5 is a close-up, magnified, view of the expansion and connector struts from FIG. 4 with micro-slits and micro-holes that extend from the outer surface of the stent struts. [0025]
  • FIG. 6([0026] a) is a cross-sectional, magnified, side view of a stent strut of the present invention illustrating micro slits that extend through both the outer and inner surfaces and the entire thickness of the stent strut.
  • FIG. 6([0027] b) is a cross-sectional, magnified, side view of the stent strut of the present invention illustrating perpendicularly extending open micro slits on one side and closed micro-slits on the opposite site of the strut.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Referring now to FIG. 1, one embodiment of an expandable stent [0028] 10 of the present invention is illustrated. A tubular structure includes an outer surface positionable adjacent to a vessel wall and an inner surface facing a lumen of a body passageway. The tubular structure further includes a plurality of expansion struts, connector struts and cells. The tubular structure has a first diameter which permits intraluminal delivery of the tubular structure into the body passageway, and a second expanded and deformed diameter which is achieved upon the application of a radially, outwardly extending force.
  • A plurality of cavities are formed in the outer surface of the stent. The cavities can be micro-holes or micro-slits and extend from the outer surface to an interior of the struts, or extend from the outer surface all the way through the inner surface. An example of a stent design useful with the present invention is disclosed in U.S. Pat. No. 5,954,743, incorporated herein by reference. In FIG. 1, a two-dimensional view of the stent [0029] 10 is illustrated and is seen from the outer surface of the cut-open, two-dimensional view.
  • Stent [0030] 10 includes expansion columns 12 and connector columns 14 in a continuous and alternating pattern to form a longitudinal dimension and a vertical dimension. The vertical and longitudinal dimensions determine the circumference and the length respectively of stent 10. Expansion columns 12 have expansion struts 16 in a vertical zigzag or corrugated pattern. One expansion column 12 is linked to an adjacent expansion column 12 by connector column 14 between two adjacent expansion 12 columns. Connector columns 14 have connector struts 18 that serve as linking arms between expansion struts 16 in two adjacent expansion columns 12. Stent 10 has a proximal end 20 and a truncated end 22 in the middle of stent 10.
  • In one embodiment, stent [0031] 10 is a tubular structure that includes patterned expansion struts 16 and connectors struts 18 continuously linked circumferentially and longitudinally with a predetermined length. The total surface areas of struts 16 and 18 are limited to a certain percent of the total cylindrical surface area of tubular stent 10, particularly when stent 10 is expanded in a vessel, with enlarged (by stent expansion) stent cells 24 that make up the remainder of the total stent surface area.
  • The amount of a coating substance applied to and retained by stent [0032] 10 is determined by the total surface area of stent struts 16 and 18. Coating substance is preferably a restenosis inhibiting agent that is a drug, polymer and bio-engineered material and combinations thereof. It will be appreciated that other types of coating substances, well known to those skilled in the art, can be applied to stent 10 of the present invention. Because the total stent strut surface areas are limited in size, the amount of coating substance applied to stent 10 is limited to a small volume. When stent 10 is expanded in a vessel the relative surface area of struts 16 and 18 decreases in relation to the areas of stent cells 24. The total cylindrical surface area of stent 10 when it is implanted and expanded inside of a vessel is equal to the sum of the strut surface areas, which do not change, and stent cells 24 areas. The size of stent cells 24 areas changes when stent 10 is expanded. The present invention increases the amount of the coating substance capacity of stent 10 without increase the metal fraction of stent 10.
  • In various embodiments, the present invention increases the coating substance retaining capacity of stent [0033] 10 by forming cavities that can be micro holes 26 which are made, punched, drilled or burned into the expansion and connector struts 16. In FIG. 1, micro holes 26 have openings 28 on outer surface of struts 16 and 18. Micro holes 26 are made and arranged in such a way so that they can be evenly distributed in struts 16 and 18. In this embodiment, micro holes 26 are evenly distributed through out the entire body of stent 10. The number of micro holes 26 illustrated in FIG. 1 is only by example.
  • The number of micro holes [0034] 26 created in stent 10 can vary by increasing or decreasing the number according to the necessity and requirements when such stents are fabricated for clinical use. Additionally, the pattern of creating micro holes 26 in stent struts 16 and 18 can be varied according to the clinical and protocol needs. Although micro holes 26 in FIG. 1 are made in straight lines it will be appreciated that micro holes 26 can be made in any varied pattern or shape. Micro-holes 26 can be made to form any suitable shape or pattern as necessary, if they meet the structural or engineering requirements of stent 10. Micro holes 26 can be made in single line or in multiple lines in struts 16 and 18 and arranged in any pattern. In the embodiment illustrated in FIG. 2, width 30 of expansion strut 16 is shown as being larger than width 32 of connector strut 18. It will be appreciated that the relative widths can change and that width 32 can be greater than width 30.
  • The size of micro holes [0035] 26 can be based on the physical dimensions of struts 16 and 18. Micro holes 26 cannot have diameters or size as large as the width of struts 16 and 18. Micro holes 26 can have substantially smaller widths or diameters than widths 30 and 32 in order to maintain the structural integrity and radial strength of stent 10. In one embodiment, micro holes 26 have an effective size or diameter to provide an optimal retaining capacity of substances or drugs that are coated or deposited on stent 10. Similarly, the distance between micro holes 26 is selected to maintain the integrity of stent 10 while providing an optimal number of micro holes 26 to provide a sufficient coating substance retaining capacity. Micro holes 26 in struts 18 can be made smaller than micro holes 26 in expansion struts 16 and visa versa.
  • Micro holes [0036] 26 and opening 28 can have more than one shape including but not limited to circular, square, oval, oblong, irregular, polygonal or a combination thereof, depending on the method used to create micro holes 26. The tools to create micro holes 26 can be mechanical, photochemical, laser, EDM and the like. The shape or configuration of micro holes 26 and openings 28 in stent struts 16 and 18 can be influenced by the size or diameter of the micro hole 26 made, as well as by other manufacturing factors such as a laser beam size, photochemical resolution or EDM cathode and the like.
  • In the embodiment of FIG. 3([0037] a), micro holes 26 penetrate the entire widths 30 and 32 of struts 16 and 18 at a perpendicular angle with opening 28 on both outer surface 34 and inner surface 36. Shaded areas 38 show the cross-sectional cut surface of struts 16 and 18. Micro holes 26 are created in a regular interval with the uninterrupted segment 28 between micro holes 26. Micro holes 26 communicate freely between outer surface 34 and inner surface 36. As can be seen, micro holes 26 increase the contact surface areas of stent struts 16 or 18 for the purpose of increasing the capacity of retaining the intended coating substance added to stent 10. The bore space of micro holes 26 also serve as micro reservoir chambers for the substance to be added, attached or coated to stent 10. When stent 10 is electropolished, the shape or dimension of micro holes 26 can be slightly changed.
  • FIG. 3([0038] b) illustrates an embodiment where micro holes 36 are blind and extend from outer surface 34 but not do not continue to inner surface 36. Shaded areas 38 indicate cross-sectioned stent struts 16 and 18. In FIG. 3(b), micro holes 26 have cul de sac geometry's 40 that terminate in an interior of struts 16 and 18. Cul-de-sacs 40 serve as reservoirs for coating substances applied to stent 10. Cul-de-sacs 40 can be created at regular or irregular intervals with uninterrupted segments 42 between that are formed between micro holes 26.
  • Referring now to FIG. 3([0039] c), micro holes 26 are shown with their axes at a slant angle relative to stent struts 16 and 18. In this embodiment, micro holes 26 extend from outer surface 34 to inner surface 36. Because micro holes 26 have a slant angle through in this embodiment, the length and reservoir capacity of the micro holes 26 is increased compared to the capacity of the FIG. 3(a) micro holes 26.
  • In the embodiment illustrated in FIG. 3([0040] d), micro holes 26 have openings 28 on outer surface 34 and cul de sacs 40 on inner surface 36, all formed at a slant angle. Outer surface 34 has uninterrupted segments 42 between slant angled micro holes 26 and inner surface 36 is smooth without openings 28. Again, cul-de-sac 40 provides a reservoir for a coating substance applied to stent 10. Because the bore space of micro holes is at a slant angle there is an increased reservoir capacity.
  • In contrast to FIG. 1, the cavities formed in FIG. 4 are micro slits, groves, and the like, collectively denoted as [0041] 40, which have widths 44 that are larger than openings 36. Compared to micro holes 26 of FIG. 1, the micro slits 40 shown in FIG. 4 provide a larger reservoir capacity for the coating substance.
  • Micro slits [0042] 40 can be evenly or unevenly distributed in struts 16 and 18. The number of micro slits 40 illustrated in FIG. 4 is only by way of example. Increasing or decreasing the number of micro slits 40 created in stent 10 may vary according to the clinical and pharmcodynamic necessity and requirements. Additionally, the pattern of creating micro slits 40 in struts 16 and 18 can vary according to the clinical and engineering needs. Although micro slits 40 illustrated in FIG. 4 are in straight lines, micro slits 40 can be made in curvilinear, square-angles, slant angled and the like with or without radius of curvature. Micro slits 40 can be made in any suitable pattern or shape as required, if they meet the structural or engineering requirements of stent 10. Micro slits 40 can be made in single line or in multiple lines in struts 16 and 18 and arranged in any other pattern. The FIG. 4 embodiment illustrates that micro holes 26 can also be included in the same stent 10.
  • The magnified view of stent [0043] 10 illustrated in FIG. 5 shows struts 16 and 18 with micro slits 40 and openings 46 on outer surface 34 of stent 10. Width 34 of expansion strut 16 is larger than width 32 of strut 18 in this embodiment. However, widths 34 and 32 can be the same in size or even reversed.
  • Width [0044] 44 of micro slit 40 is determined by the physical dimensions and limits of struts 16 and 18. Width 44 can not be made as large as widths 34 and 32. Width 44 is substantially smaller than width 34 in order to maintain the structural integrity and radial strength of stent 10. The length of micro slit 40 can be made as long as stent struts 16 and 18. The length of micro slit 40 can be shorter or longer than the width of struts 16 and 18. Similarly, the uninterrupted distance 42 between micro slits 40 is selected so that the structural integrity of stent 10 is not compromised. Within the allowable limits, micro slits 40 can be made in different sizes or dimensions in same or differing patterns. Micro slits 40 in struts 18 can be made smaller than, the same as or greater than micro-slits 40 formed in struts 16.
  • The shape of micro slits [0045] 40 and opening 46 can be different than that illustrated in FIG. 5. The geometry of micro slits 40 can be straight linear, curvilinear, angled, squared or any other shape, depending on the design of stent 10 and the method used to make micro slits 40 during the manufacturing process. The tools to create the micro slits 40 can be the same as those used for micro-holes 26. Different shapes, sizes and positions of micro slits 40 can be included in an individual stent 10.
  • Referring now to FIG. 6([0046] a), micro slits 40 can extend through struts 16 and 18 with openings 50 on both outer and inner surfaces 34 and 36. Micro slits 40 can be created in a regular interval with uninterrupted segment 42 between micro slits 40.
  • Additionally, in this embodiment micro slits [0047] 40 can communicate freely between outer surface 34 inner surface 36. Micro slits 40 increase coating substance contact surface areas of struts 16 and 18 for the purpose of increasing the reservoir capacity of intended coating substances.
  • FIG. 6([0048] b) illustrates that blind micro slits 40 partially extend into struts 16 and 18 from outer surface 34. Blind micro slits 40 end in cul-de-sacs 48 which can be of any desired geometric configuration. Cul-de-sacs 48 create micro reservoirs 50 for coating substances and can be formed at regular or irregular intervals with uninterrupted segments 42 between blind micro slits 48. Generally, the reservoir capacity of blind micro slits 40 is greater than that of blind micro holes 26. Additionally, Micro slits 40 can also be made in slant angles.
  • The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents. [0049]

Claims (64)

What is claimed is:
1. An expandable stent, comprising:
a tubular structure including an outer surface positionable adjacent to a vessel wall, an inner surface facing a lumen of a body passageway, a plurality of expansion struts, connector struts and cells, the tubular structure having a first diameter which permits intraluminal delivery of the tubular structure into the body passageway having a lumen, and a second expanded and deformed diameter upon the application from the interior of the tubular member of a radially, outwardly extending force; and
a plurality of cavities formed in the outer surface of the stent.
2. The stent of claim 1, wherein the tubular structure is balloon expandable.
3. The stent of claim 1, wherein the tubular structure is self-expandable.
4. The stent of claim 1, wherein at least a portion of the tubular structure is made of a shape memory alloy.
5. The stent of claim 1, wherein the plurality of cavities are substantially evenly positioned on the tubular structure.
6. The stent of claim 1 wherein the plurality of cavities increase a flexibility of the stent without substantially reducing a radial strength of the stent in a deployed state.
7. The stent of claim 1, wherein the plurality of cavities are micro-holes that extend from the outer surface.
8. The stent of claim 7, wherein the micro-holes have a cross-section that is smaller than a cross section of a strut.
9. The stent of claim 7, wherein the micro-holes extend from the outer surface through the inner surface.
10. The stent of claim 7, wherein the micro-holes extend from the outer surface to an interior of the tubular structure without extending through the inner surface.
11. The stent of claim 7, wherein at least a portion of the micro-holes extend from the outer surface through the inner surface and at least a portion extend from the outer surface to an interior of the tubular structure without extending through the inner surface.
12. The stent of claim 7, wherein at least a portion of the micro-holes have geometry's that are configured to provide a reservoir for a coating substance applied to the tubular structure.
13. The stent of claim 7, wherein at least a portion of the micro-holes have a diameter of at least 0.0007 inch.
14. The stent of claim 7, wherein at least a portion of the micro-holes extend perpendicular from the outer surface to an interior of the tubular structure.
15. The stent of claim 7, wherein at least a portion of the micro-holes extend at a non- perpendicular slant angle from the outer surface to an interior of the tubular structure.
16. The stent of claim 1, wherein the plurality of cavities are micro-slits that extend from the outer surface.
17. The stent of claim 16, wherein the micro-slits have a cross-section that is smaller than a cross section of a strut.
18. The stent of claim 16, wherein the micro-slits extend from the outer surface through the inner surface.
19. The stent of claim 16, wherein the micro-slits extend from the outer surface to an interior of the tubular structure without extending through the inner surface.
20. The stent of claim 16, wherein at least a portion of the micro-slits extend from the outer surface through the inner surface and at least a portion extend from the outer surface to an interior of the tubular structure without extending through the inner surface
21. The stent of claim 16, wherein at least a portion of the micro-slits have geometry's that are configured to provide a reservoir for a coating substance applied to the tubular structure.
22. The stent of claim 16, wherein at least a portion of the micro-slits have a width of at least 0.0007 inch.
23. The stent of claim 16, wherein at least a portion of the micro slits have a width greater than 0.0007 inch.
24. The stent of claim 16, wherein at least a portion of the micro slits have a length of at least 0.001 inch.
25. The stent of claim 16, wherein at least a portion of the micro slits have a length greater than 0.001 inch.
26. The stent of claim 16, wherein at least a portion of the micro-slits extend perpendicular from the outer surface to an interior of the tubular structure.
27. The stent of claim 16, wherein at least a portion of the micro-slits extend at a non- perpendicular slant angle from the outer surface to an interior of the tubular structure.
28. The stent of claim 16, wherein at least a portion of the micro-slits have a linear geometric shape.
29. The stent of claim 16, wherein at least a portion of the micro-slits have a curved geometric shape.
30. The stent of claim 16, wherein at least a portion of the micro-slits have a bottom surface formed in an interior of the tubular structure.
31. The stent of claim 30, further including at least one aperture that extends from the bottom surface of a micro-slit through the inner surface.
32. The stent of claim 30, further including a plurality of apertures that extend from the bottom surface of the micro-slit through the inner surface.
33. The stent of claim 1, further comprising:
a coating substance on at least a portion of outer surface of the stent including at least a portion of the plurality of cavities.
34. The stent of claim 33, wherein the coating substance is a restenosis inhibiting agent.
35. The stent of claim 34, wherein the restenonis inhibiting agent is selected from a drug, polymer and bio-engineered material.
36. The stent of claim 34, wherein the restenonis inhibiting agent is a combination of two agents selected from a drug, polymer and bio-engineered material.
37. The stent of claim 34, wherein each of a cavity of the plurality of cavities is configured to have a shape adapted to increase an amount of restenosis inhibiting agent coated on the stent.
38. The stent of claim 33, wherein each of a cavity of the plurality of cavities is configured to have a shape adapted to provide reservoir of the coated substance on the stent.
39. An expandable stent, comprising:
a tubular structure including an outer surface positionable adjacent to a vessel wall, an inner surface facing a lumen of a body passageway, a plurality of expansion struts, connector struts and cells, the tubular structure having a first diameter which permits intraluminal delivery of the tubular structure into the body passageway having a lumen, and a second expanded and deformed diameter upon the application from the interior of the tubular member of a radially, outwardly extending force;
a plurality of cavities formed in the outer surface of the stent; and
a coating substance on at least a portion of outer surface of the stent including and extending into at least a portion of the cavities.
40. The stent of claim 39, wherein the coating substance is on at least a portion of the inner surface of the stent.
41. The stent of claim 39, wherein the coating substance is a restenosis inhibiting agent.
42. The stent of claim 41, wherein the restenonis inhibiting agent is selected from a drug, polymer and bio-engineered material.
43. The stent of claim 34, wherein the restenonis inhibiting agent is a combination of two agents selected from a drug, polymer and bio-engineered material.
44. The stent of claim 40, wherein each of a cavity of the plurality of cavities is configured to have a shape adapted to increase an amount of restenosis inhibiting agent coated on the stent.
45. The stent of claim 39, wherein each of a cavity of the plurality of cavities is configured to have a shape adapted to provide a reservoir of the coated substance on the stent.
46. The stent of claim 39, wherein the tubular structure is balloon expandable.
47. The stent of claim 39, wherein the tubular structure is self-expandable.
48. The stent of claim 39, wherein at least a portion of the tubular structure is made of a shape memory alloy.
49. The stent of claim 39, wherein the plurality of cavities are substantially evenly positioned on the tubular structure.
50. The stent of claim 39, wherein the plurality of cavities increase a flexibility of the stent without substantially reducing a radial strength of the stent in a deployed state.
51. The stent of claim 39, wherein the plurality of cavities are micro-holes that extend from the outer surface.
52. The stent of claim 51, wherein the micro-holes have a cross-section that is smaller than a cross section of a strut.
53. The stent of claim 39, wherein the plurality of cavities are micro-slits that extend from the outer surface.
54. The stent of claim 55, wherein the micro-slits have a cross-section that is smaller than a cross section of a strut.
55. A stent assembly, comprising:
a balloon; and
an expandable stent positioned at an exterior of the balloon, the stent including,
a tubular structure including an outer surface positionable adjacent to a vessel wall, an inner surface facing a lumen of a body passageway, a plurality of expansion struts, connector struts and cells, the tubular structure having a first diameter which permits intraluminal delivery of the tubular structure into the body passageway having a lumen, and a second expanded and deformed diameter upon the application from the interior of the tubular member of a radially, outwardly extending force applied by the balloon;
a plurality of cavities formed in the outer surface of the stent; and
a coating substance on at least a portion of outer surface of the stent including and extending into at least a portion of the cavities.
56. The stent of claim 55, wherein the coating substance is on at least a portion of the inner surface of the stent.
57. The stent of claim 55, wherein the coating substance is a restenosis inhibiting agent.
58. The stent of claim 55, wherein the restenonis inhibiting agent is selected from a drug, polymer and bio-engineered material.
59. The stent of claim 55, wherein each of a cavity of the plurality of cavities is configured to have a shape adapted to increase an amount of restenosis inhibiting agent coated on the stent.
60. The stent of claim 55, wherein each of a cavity of the plurality of cavities is configured to have a shape adapted to provide a reservoir of the coated substance on the stent.
61. A method of manufacturing an intravascular stent, comprising:
forming an intravascular stent having an inner surface and an outer surface; and
forming a plurality of cavities on the outer surface of the intravascular stent; and
disposing on at least a portion of the outer surface and at least a portion of the plurality of cavities a coating substance that inhibits restenosis.
62. The method of claim 61, wherein at least a portion of the plurality of cavities is formed on the outer surface of the intravascular stent by a laser.
63. The method of claim 61, wherein the at least a portion of the plurality of cavities is formed on the outer surface of the intravascular stent by EDM.
64. The method of claim 61, wherein the at least a portion of the plurality of cavities is photochemically formed on the outer surface of the intravascular stent.
US09/874,349 2000-06-05 2001-06-04 Intravascular stent with increasing coating retaining capacity Active US6783543B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US20925500P true 2000-06-05 2000-06-05
US23516400P true 2000-09-23 2000-09-23
US09/874,349 US6783543B2 (en) 2000-06-05 2001-06-04 Intravascular stent with increasing coating retaining capacity

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09/874,349 US6783543B2 (en) 2000-06-05 2001-06-04 Intravascular stent with increasing coating retaining capacity
CA002449484A CA2449484A1 (en) 2001-06-04 2002-06-03 Intravascular stent with increasing coating retaining capacity
JP2003501371A JP2004528928A (en) 2001-06-04 2002-06-03 Vascular stent with enhanced coating holding capacity
EP20020739660 EP1397091A1 (en) 2001-06-04 2002-06-03 Intravascular stent with increasing coating retaining capacity
PCT/US2002/017626 WO2002098326A1 (en) 2001-06-04 2002-06-03 Intravascular stent with increasing coating retaining capacity
US10/374,774 US20040106985A1 (en) 1996-04-26 2003-02-25 Intravascular stent
US10/419,280 US20040093071A1 (en) 2000-06-05 2003-04-17 Intravascular stent with increasing coating retaining capacity
US12/192,782 US9445926B2 (en) 1996-04-26 2008-08-15 Intravascular stent
US13/325,916 US20120085734A1 (en) 2000-06-05 2011-12-14 Extendible Stent Apparatus

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/487,522 Continuation US20090254173A1 (en) 2000-06-05 2009-06-18 Extendible stent apparatus

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/374,774 Continuation-In-Part US20040106985A1 (en) 1996-04-26 2003-02-25 Intravascular stent
US10/419,280 Continuation US20040093071A1 (en) 2000-06-05 2003-04-17 Intravascular stent with increasing coating retaining capacity

Publications (3)

Publication Number Publication Date
US20020038145A1 true US20020038145A1 (en) 2002-03-28
US20040148012A9 US20040148012A9 (en) 2004-07-29
US6783543B2 US6783543B2 (en) 2004-08-31

Family

ID=25363552

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/874,349 Active US6783543B2 (en) 2000-06-05 2001-06-04 Intravascular stent with increasing coating retaining capacity
US10/419,280 Abandoned US20040093071A1 (en) 2000-06-05 2003-04-17 Intravascular stent with increasing coating retaining capacity
US13/325,916 Abandoned US20120085734A1 (en) 2000-06-05 2011-12-14 Extendible Stent Apparatus

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/419,280 Abandoned US20040093071A1 (en) 2000-06-05 2003-04-17 Intravascular stent with increasing coating retaining capacity
US13/325,916 Abandoned US20120085734A1 (en) 2000-06-05 2011-12-14 Extendible Stent Apparatus

Country Status (5)

Country Link
US (3) US6783543B2 (en)
EP (1) EP1397091A1 (en)
JP (1) JP2004528928A (en)
CA (1) CA2449484A1 (en)
WO (1) WO2002098326A1 (en)

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020018795A1 (en) * 2000-04-13 2002-02-14 Whitbourne Richard J. Targeted therapeutic agent release devices and methods of making and using the same
US20020062149A1 (en) * 1996-04-26 2002-05-23 Jang G. David Intravascular stent
US20020107563A1 (en) * 2001-02-05 2002-08-08 Shanley John F. Expandable medical device with locking mechanism
US20020121497A1 (en) * 2001-03-01 2002-09-05 Tomonto Charles V. Flexible stent and method of manufacture
US20020161429A1 (en) * 1996-04-26 2002-10-31 Jang G. David Intravascular stent
US20020169500A1 (en) * 1996-04-26 2002-11-14 Jang G. David Intravascular stent
US20030009214A1 (en) * 1998-03-30 2003-01-09 Shanley John F. Medical device with beneficial agent delivery mechanism
WO2003015664A1 (en) * 2001-08-20 2003-02-27 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20030068355A1 (en) * 2001-08-20 2003-04-10 Shanley John F. Therapeutic agent delivery device with protective separating layer
US20030093144A1 (en) * 1998-02-02 2003-05-15 Scimed Life Systems, Inc. Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal-connectors
US20030195613A1 (en) * 1996-12-30 2003-10-16 Sorin Biomedica Cardio S.P.A. Stent for angioplasty and associated production process
US20030199970A1 (en) * 1998-03-30 2003-10-23 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20040073294A1 (en) * 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20040106985A1 (en) * 1996-04-26 2004-06-03 Jang G. David Intravascular stent
US20040127976A1 (en) * 2002-09-20 2004-07-01 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20040133271A1 (en) * 2000-09-22 2004-07-08 Jang G. David Intravascular stent and assembly
US6764507B2 (en) * 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
US20040143321A1 (en) * 2002-11-08 2004-07-22 Conor Medsystems, Inc. Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
US20040143322A1 (en) * 2002-11-08 2004-07-22 Conor Medsystems, Inc. Method and apparatus for treating vulnerable artherosclerotic plaque
US20040172124A1 (en) * 2001-07-20 2004-09-02 Sorin Biomedica Cardio S.P.A. Angioplasty stents
US20040186553A1 (en) * 1997-04-15 2004-09-23 Yan John Y. Medicated porous metal prosthesis and a method of making the same
US20040193255A1 (en) * 2003-03-28 2004-09-30 Shanley John F. Therapeutic agent delivery device with controlled therapeutic agent release rates
US20040204756A1 (en) * 2004-02-11 2004-10-14 Diaz Stephen Hunter Absorbent article with improved liquid acquisition capacity
US20040202692A1 (en) * 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device and method for in situ selective modulation of agent delivery
US6805898B1 (en) * 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
US20040220662A1 (en) * 2000-10-30 2004-11-04 Dang Kenny L. Increased drug-loading and reduced stress drug delivery device
US20040220660A1 (en) * 2001-02-05 2004-11-04 Shanley John F. Bioresorbable stent with beneficial agent reservoirs
US20040225350A1 (en) * 1998-03-30 2004-11-11 Shanley John F. Expandable medical device for delivery of beneficial agent
US20040249443A1 (en) * 2001-08-20 2004-12-09 Shanley John F. Expandable medical device for treating cardiac arrhythmias
US20040249449A1 (en) * 2003-06-05 2004-12-09 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery
US20040254635A1 (en) * 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US20050010170A1 (en) * 2004-02-11 2005-01-13 Shanley John F Implantable medical device with beneficial agent concentration gradient
US20050100577A1 (en) * 2003-11-10 2005-05-12 Parker Theodore L. Expandable medical device with beneficial agent matrix formed by a multi solvent system
US20050118344A1 (en) * 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US20050182390A1 (en) * 2004-02-13 2005-08-18 Conor Medsystems, Inc. Implantable drug delivery device including wire filaments
US20050209680A1 (en) * 1997-04-15 2005-09-22 Gale David C Polymer and metal composite implantable medical devices
US20050222677A1 (en) * 1995-06-07 2005-10-06 Bates Brian L Coated implantable medical device
US20050222676A1 (en) * 2003-09-22 2005-10-06 Shanley John F Method and apparatus for loading a beneficial agent into an expandable medical device
US20050234544A1 (en) * 2002-09-20 2005-10-20 Conor Medsystems, Inc. Expandable medical device with openings for delivery of multiple beneficial agents
EP1604697A1 (en) * 2004-06-09 2005-12-14 J.A.C.C. GmbH Implantable device
US20050283229A1 (en) * 1997-04-15 2005-12-22 Steve Dugan Coatings for controlling erosion of a substrate of an implantable medical device
US6979347B1 (en) * 2000-10-23 2005-12-27 Advanced Cardiovascular Systems, Inc. Implantable drug delivery prosthesis
US20050287287A1 (en) * 2004-06-24 2005-12-29 Parker Theodore L Methods and systems for loading an implantable medical device with beneficial agent
US20060122697A1 (en) * 2002-09-20 2006-06-08 Conor Medsystems, Inc. Expandable medical device with openings for delivery of multiple beneficial agents
US20060129231A1 (en) * 2000-03-06 2006-06-15 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US20060147489A1 (en) * 2003-03-28 2006-07-06 Conor Medsystems, Inc. Implantable medical device with beneficial agent concentration gradient
US7135038B1 (en) 2002-09-30 2006-11-14 Advanced Cardiovascular Systems, Inc. Drug eluting stent
US20070043423A1 (en) * 2005-08-10 2007-02-22 Med Institute Inc. Intraluminal device with a hollow structure
US20080147166A1 (en) * 1995-06-07 2008-06-19 Bates Brian L Coated implantable medical device
US20080145399A1 (en) * 1995-06-07 2008-06-19 Bates Brian L Coated implantable medical device
US20080183270A1 (en) * 2007-01-30 2008-07-31 Medtronic Vascular, Inc. Stent With Longitudinal Groove
US20080183281A1 (en) * 2007-01-30 2008-07-31 Medtronic Vascular, Inc. Implantable Device With Reservoirs for Increased Drug Loading
US20080215138A1 (en) * 1995-06-07 2008-09-04 Bates Brian L Coated implantable medical device
US20090076591A1 (en) * 2007-09-19 2009-03-19 Boston Scientific Scimed, Inc. Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
US20100023115A1 (en) * 2008-07-23 2010-01-28 Boston Scientific Scimed, Inc. Drug-eluting stent
US20100217380A1 (en) * 2009-02-02 2010-08-26 Ryan Donovan Flexible stent design
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
US20110008529A1 (en) * 1999-09-03 2011-01-13 Advanced Cardiovascular Systems, Inc. Thermal Treatment Of An Implantable Medical Device
US20110262621A1 (en) * 2002-11-07 2011-10-27 Abbott Laboratores Method of loading beneficial agent on a prosthesis
US20140277382A1 (en) * 2013-03-14 2014-09-18 Medtronic Vascular, Inc. Method for Manufacturing a Stent and Stent Manufactured Thereby
US8900292B2 (en) * 2007-08-03 2014-12-02 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US8920489B2 (en) 2010-08-02 2014-12-30 Cordis Corporation Flexible stent having protruding hinges
CN104287878A (en) * 2014-09-16 2015-01-21 李宝童 Blood intra-cavity support
US8961590B2 (en) 2010-08-02 2015-02-24 Cordis Corporation Flexible helical stent having different helical regions
US9095459B2 (en) 2009-09-30 2015-08-04 Terumo Kabushiki Kaisha Stent with drug coat layer including a gradual stepwise decrease portion
US20150250772A1 (en) * 2011-08-25 2015-09-10 Boston Scientific Scimed, Inc. Medical Device with Crystalline Drug Coating
US9155644B2 (en) 2010-08-02 2015-10-13 Cordis Corporation Flexible helical stent having intermediate structural feature
USRE45744E1 (en) 2003-12-01 2015-10-13 Abbott Cardiovascular Systems Inc. Temperature controlled crimping
US10231855B2 (en) 2010-08-02 2019-03-19 CARDINAL HEALTH SWITZERLAND 515 GmbH Flexible helical stent having intermediate non-helical region

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP0797988B1 (en) * 1993-07-19 2009-01-14 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
US7070590B1 (en) * 1996-07-02 2006-07-04 Massachusetts Institute Of Technology Microchip drug delivery devices
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
EP2308522A3 (en) 1999-11-17 2012-02-29 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
DE60027458T2 (en) * 1999-12-10 2007-07-05 Massachusetts Institute Of Technology, Cambridge Microchip drug administration systems and manufacturing processes
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
AT525977T (en) 2000-06-05 2011-10-15 Boston Scient Ltd Intravascular stent with improved stamina of a coating
CA2428572C (en) * 2000-11-13 2010-01-12 Michelin Recherche Et Technique S.A. Pneumatic tire tread
US7771468B2 (en) * 2001-03-16 2010-08-10 Angiotech Biocoatings Corp. Medicated stent having multi-layer polymer coating
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
AU2002345328A1 (en) 2001-06-27 2003-03-03 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US7223282B1 (en) * 2001-09-27 2007-05-29 Advanced Cardiovascular Systems, Inc. Remote activation of an implantable device
US7014654B2 (en) * 2001-11-30 2006-03-21 Scimed Life Systems, Inc. Stent designed for the delivery of therapeutic substance or other agents
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
AU2012203972B2 (en) * 2002-09-20 2015-09-03 Innovational Holdings, Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US7169178B1 (en) * 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
US7316710B1 (en) * 2002-12-30 2008-01-08 Advanced Cardiovascular Systems, Inc. Flexible stent
DE602004031011D1 (en) * 2003-04-25 2011-02-24 Boston Scient Scimed Inc Solid pharmaceutical formulation and device for its retention and controlled delivery
EP1633434B1 (en) 2003-06-04 2014-11-19 Synecor Intravascular electrophysiological system
US7082336B2 (en) * 2003-06-04 2006-07-25 Synecor, Llc Implantable intravascular device for defibrillation and/or pacing
US8239045B2 (en) 2003-06-04 2012-08-07 Synecor Llc Device and method for retaining a medical device within a vessel
US7617007B2 (en) 2003-06-04 2009-11-10 Synecor Llc Method and apparatus for retaining medical implants within body vessels
US8999364B2 (en) 2004-06-15 2015-04-07 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US8435285B2 (en) * 2003-11-25 2013-05-07 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
US7747335B2 (en) 2003-12-12 2010-06-29 Synecor Llc Implantable medical device having pre-implant exoskeleton
US20050228477A1 (en) * 2004-04-09 2005-10-13 Xtent, Inc. Topographic coatings and coating methods for medical devices
WO2005122959A2 (en) 2004-06-08 2005-12-29 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
US20050278929A1 (en) * 2004-06-16 2005-12-22 National Taipei University Technology Process of manufacturing stent with therapeutic function in the human body
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US20060025848A1 (en) * 2004-07-29 2006-02-02 Jan Weber Medical device having a coating layer with structural elements therein and method of making the same
US20060253193A1 (en) * 2005-05-03 2006-11-09 Lichtenstein Samuel V Mechanical means for controlling blood pressure
JP4797473B2 (en) * 2005-07-11 2011-10-19 ニプロ株式会社 Extension of the excellent flexible stent
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US20070173924A1 (en) * 2006-01-23 2007-07-26 Daniel Gelbart Axially-elongating stent and method of deployment
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
EP1998716A4 (en) 2006-03-20 2010-01-20 Xtent Inc Apparatus and methods for deployment of linked prosthetic segments
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US20070275035A1 (en) * 2006-05-24 2007-11-29 Microchips, Inc. Minimally Invasive Medical Implant Devices for Controlled Drug Delivery
US20070276444A1 (en) * 2006-05-24 2007-11-29 Daniel Gelbart Self-powered leadless pacemaker
US20070287879A1 (en) * 2006-06-13 2007-12-13 Daniel Gelbart Mechanical means for controlling blood pressure
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
US8771343B2 (en) 2006-06-29 2014-07-08 Boston Scientific Scimed, Inc. Medical devices with selective titanium oxide coatings
CA2659761A1 (en) 2006-08-02 2008-02-07 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
JP2010503469A (en) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド Medical device having a drug eluting coating
EP2959925B1 (en) 2006-09-15 2018-08-29 Boston Scientific Limited Medical devices and methods of making the same
AT517590T (en) 2006-09-15 2011-08-15 Boston Scient Ltd Bioerodible endoprostheses
US8808726B2 (en) 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
ES2368125T3 (en) 2006-09-15 2011-11-14 Boston Scientific Scimed, Inc. bioerodible endoprostheses biostable inorganic layers.
CA2663762A1 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
US20080085486A1 (en) * 2006-10-04 2008-04-10 Injectamax Corporation Malleable Orthodontic Bracket
US7951191B2 (en) 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20080140179A1 (en) * 2006-12-12 2008-06-12 Ladisa John F Apparatus and method for minimizing flow disturbances in a stented region of a lumen
DE602007010669D1 (en) 2006-12-28 2010-12-30 Boston Scient Ltd hear it
JP2010516393A (en) * 2007-01-29 2010-05-20 クック・インコーポレイテッドCook Incorporated Medical prostheses and a method of manufacturing
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8431149B2 (en) * 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8646444B2 (en) * 2007-03-27 2014-02-11 Electrolux Home Products, Inc. Glide rack
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
WO2008127966A1 (en) * 2007-04-11 2008-10-23 Boston Scientific Scimed, Inc. Photoresist coating to apply a coating to select areas of a medical device
US20080275543A1 (en) * 2007-05-02 2008-11-06 Boston Scientific Scimed, Inc. Stent
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US7637940B2 (en) * 2007-07-06 2009-12-29 Boston Scientific Scimed, Inc. Stent with bioabsorbable membrane
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US9284409B2 (en) 2007-07-19 2016-03-15 Boston Scientific Scimed, Inc. Endoprosthesis having a non-fouling surface
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
US7959669B2 (en) 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US7722661B2 (en) * 2007-12-19 2010-05-25 Boston Scientific Scimed, Inc. Stent
US8277501B2 (en) 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
WO2009132176A2 (en) 2008-04-24 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
WO2009155328A2 (en) 2008-06-18 2009-12-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US20090319026A1 (en) * 2008-06-20 2009-12-24 Boston Scientific Scimed, Inc. Composite Stent with Reservoirs for Drug Delivery and Methods of Manufacturing
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8267992B2 (en) 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US8888840B2 (en) * 2009-05-20 2014-11-18 Boston Scientific Scimed, Inc. Drug eluting medical implant
US20110319987A1 (en) * 2009-05-20 2011-12-29 Arsenal Medical Medical implant
JP5820370B2 (en) * 2009-05-20 2015-11-24 アーセナル メディカル, インコーポレイテッド Medical implants
US9283305B2 (en) 2009-07-09 2016-03-15 Medtronic Vascular, Inc. Hollow tubular drug eluting medical devices
WO2011008393A2 (en) 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US8828474B2 (en) 2009-09-20 2014-09-09 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8381774B2 (en) * 2009-09-20 2013-02-26 Medtronic Vascular, Inc. Methods for loading a drug eluting medical device
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US20110070358A1 (en) 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
EP2338534A2 (en) * 2009-12-21 2011-06-29 Biotronik VI Patent AG Medical implant, coating method and implantation method
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
US8632846B2 (en) 2010-09-17 2014-01-21 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9381103B2 (en) * 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US628413A (en) * 1898-02-25 1899-07-04 Frank Mcmillan Kinetoscopic apparatus.
US637381A (en) * 1899-04-11 1899-11-21 Atlas Tack Company Nail-making machine.
US658121A (en) * 1899-12-18 1900-09-18 Peter Albert Prudhomme Trace-carrier.
US4289510A (en) * 1980-01-21 1981-09-15 Conor Corporation Internal loading cylindrical filter with unsupported tubular filter fabric
DK71987D0 (en) * 1987-02-13 1987-02-13 Nordiske Kabel Traad Method of cleaning oil and chemical contaminated soil
US5810767A (en) 1994-05-11 1998-09-22 Localmed, Inc. Method and apparatus for pressurized intraluminal drug delivery
US5523092A (en) 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
AT220308T (en) 1995-03-01 2002-07-15 Scimed Life Systems Inc Longitudinal Flexible and expandable stent
AT169484T (en) 1995-04-01 1998-08-15 Variomed Ag Stent for transluminal implantation in hollow organs
US6280413B1 (en) 1995-06-07 2001-08-28 Medtronic Ave, Inc. Thrombolytic filtration and drug delivery catheter with a self-expanding portion
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5895406A (en) 1996-01-26 1999-04-20 Cordis Corporation Axially flexible stent
US6152957A (en) 1996-04-26 2000-11-28 Jang; G. David Intravascular stent
US6261320B1 (en) * 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
US5922020A (en) 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
ZA9710342B (en) 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
IT1289815B1 (en) * 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa Stent for angioplasty and relative production method
AU737252B2 (en) 1997-02-20 2001-08-16 Cook Medical Technologies Llc Coated implantable medical device
US6240616B1 (en) * 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
US5843172A (en) 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
US6273913B1 (en) 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
WO1999001088A1 (en) 1997-07-04 1999-01-14 Alain Fouere Flexible and expansible internal vascular prosthesis for surgical use
EP1017336B1 (en) 1997-09-24 2007-08-15 Med Institute, Inc. Radially expandable stent
US6042606A (en) 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
US5972027A (en) 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6273908B1 (en) 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
DE69830605T3 (en) 1997-11-07 2012-02-09 Expandable Grafts Partnership Intravascular stent and manufacturing processes for
US6132461A (en) * 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent with dual support structure
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6293967B1 (en) * 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6206916B1 (en) 1998-04-15 2001-03-27 Joseph G. Furst Coated intraluminal graft
US20020038146A1 (en) * 1998-07-29 2002-03-28 Ulf Harry Expandable stent with relief cuts for carrying medicines and other materials
US6206915B1 (en) 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent
DE19855421C2 (en) * 1998-11-02 2001-09-20 Alcove Surfaces Gmbh implant
US6109358A (en) * 1999-02-05 2000-08-29 Conor Pacific Environmental Technologies Inc. Venting apparatus and method for remediation of a porous medium
US6558422B1 (en) 1999-03-26 2003-05-06 University Of Washington Structures having coated indentations
US6290673B1 (en) * 1999-05-20 2001-09-18 Conor Medsystems, Inc. Expandable medical device delivery system and method
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
US20010032011A1 (en) * 1999-07-20 2001-10-18 Stanford Ulf Harry Expandable stent with array of relief cuts
DE60018582T2 (en) * 1999-08-18 2006-01-19 Microchips, Inc., Bedford Thermally activated microchip as a delivery device for chemicals
US6287628B1 (en) * 1999-09-03 2001-09-11 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US6379381B1 (en) * 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
WO2001026584A1 (en) 1999-10-14 2001-04-19 United Stenting, Inc. Stents with multilayered struts
EP2308522A3 (en) * 1999-11-17 2012-02-29 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
AU5289001A (en) * 2000-03-02 2001-09-12 Microchips Inc Microfabricated devices for the storage and selective exposure of chemicals and devices
EP1132058A1 (en) 2000-03-06 2001-09-12 Advanced Laser Applications Holding S.A. Intravascular prothesis
WO2001091918A1 (en) 2000-05-31 2001-12-06 Advanced Cardiovascular Systems, Inc. An apparatus and method for forming a coating onto a surface of a prosthesis
US6395326B1 (en) * 2000-05-31 2002-05-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for depositing a coating onto a surface of a prosthesis
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
AT525977T (en) 2000-06-05 2011-10-15 Boston Scient Ltd Intravascular stent with improved stamina of a coating
US6254632B1 (en) 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment
US6773429B2 (en) * 2000-10-11 2004-08-10 Microchips, Inc. Microchip reservoir devices and facilitated corrosion of electrodes
WO2002032347A2 (en) * 2000-10-16 2002-04-25 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7208010B2 (en) * 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6764507B2 (en) * 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
US6506437B1 (en) 2000-10-17 2003-01-14 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device having depots formed in a surface thereof
US6758859B1 (en) * 2000-10-30 2004-07-06 Kenny L. Dang Increased drug-loading and reduced stress drug delivery device
DE60202468T2 (en) * 2001-06-28 2006-02-16 Microchips, Inc., Bedford A method for hermetically seal microchip reservoir devices
US7014654B2 (en) * 2001-11-30 2006-03-21 Scimed Life Systems, Inc. Stent designed for the delivery of therapeutic substance or other agents
US20040073294A1 (en) * 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
AU2003276920A1 (en) * 2002-09-20 2004-04-08 Innovational Holdings, Llc Expandable medical device with openings for delivery of multiple beneficial agents
US20040127976A1 (en) * 2002-09-20 2004-07-01 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
WO2004043509A1 (en) * 2002-11-08 2004-05-27 Conor Medsystems, Inc. Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
EP2338538A1 (en) * 2002-11-08 2011-06-29 Conor Medsystems, Inc. Method and apparatus for reducing tissue damage after ischemic injury
US20040142014A1 (en) * 2002-11-08 2004-07-22 Conor Medsystems, Inc. Method and apparatus for reducing tissue damage after ischemic injury
US20040202692A1 (en) * 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device and method for in situ selective modulation of agent delivery
US7169179B2 (en) * 2003-06-05 2007-01-30 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery

Cited By (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8469943B2 (en) 1995-06-07 2013-06-25 Cook Medical Technologies Llc Coated implantable medical device
US20080145399A1 (en) * 1995-06-07 2008-06-19 Bates Brian L Coated implantable medical device
US20090285975A1 (en) * 1995-06-07 2009-11-19 Bates Brian L Methods for making implantable medical devices
US8945206B2 (en) 1995-06-07 2015-02-03 Cook Medical Technologies Llc Methods for making implantable medical devices
US20110046723A1 (en) * 1995-06-07 2011-02-24 Bates Brian L Coated implantable medical device
US8257433B2 (en) 1995-06-07 2012-09-04 Cook Medical Technologies Llc Coated implantable medical device
US7896914B2 (en) 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
US20060195176A1 (en) * 1995-06-07 2006-08-31 Cook Incorporated Coated implantable medical device
US8556962B2 (en) 1995-06-07 2013-10-15 Cook Medical Technologies Llc Coated implantable medical device
US8758428B2 (en) * 1995-06-07 2014-06-24 Cook Medical Technologies Llc Coated implantable medical device
US20080215138A1 (en) * 1995-06-07 2008-09-04 Bates Brian L Coated implantable medical device
US20080147166A1 (en) * 1995-06-07 2008-06-19 Bates Brian L Coated implantable medical device
US20080145398A1 (en) * 1995-06-07 2008-06-19 Bates Brian L Coated implantable medical device
US7901453B2 (en) * 1995-06-07 2011-03-08 Cook Incorporated Coated implantable medical device
US20050222677A1 (en) * 1995-06-07 2005-10-06 Bates Brian L Coated implantable medical device
US20020193870A1 (en) * 1996-04-26 2002-12-19 Jang G. David Intravascular stent
US20040106985A1 (en) * 1996-04-26 2004-06-03 Jang G. David Intravascular stent
US9078778B2 (en) 1996-04-26 2015-07-14 Boston Scientific Scimed, Inc. Intravascular stent
US20020169500A1 (en) * 1996-04-26 2002-11-14 Jang G. David Intravascular stent
US20020161430A1 (en) * 1996-04-26 2002-10-31 Jang G. David Intravascular stent
US20020161429A1 (en) * 1996-04-26 2002-10-31 Jang G. David Intravascular stent
US8021414B2 (en) 1996-04-26 2011-09-20 Boston Scientific Scimed, Inc. Intravascular stent
US20020062149A1 (en) * 1996-04-26 2002-05-23 Jang G. David Intravascular stent
US20080300674A1 (en) * 1996-04-26 2008-12-04 Boston Scientific Scimed, Inc. Intravascular Stent
US9445926B2 (en) 1996-04-26 2016-09-20 Boston Scientific Scimed, Inc. Intravascular stent
US20100216376A1 (en) * 1996-12-30 2010-08-26 Sorin Biomedica Cardio S.R.L. Process for producing a stent for angioplasty
US7607208B2 (en) 1996-12-30 2009-10-27 Sorin Biomedica Cardio S.R.L. Method of making a medicated stent
US20030195613A1 (en) * 1996-12-30 2003-10-16 Sorin Biomedica Cardio S.P.A. Stent for angioplasty and associated production process
US7946019B2 (en) 1996-12-30 2011-05-24 Sorin Biomedica Cardio S.R.L. Process for producing a stent for angioplasty
US10028851B2 (en) 1997-04-15 2018-07-24 Advanced Cardiovascular Systems, Inc. Coatings for controlling erosion of a substrate of an implantable medical device
US7699890B2 (en) 1997-04-15 2010-04-20 Advanced Cardiovascular Systems, Inc. Medicated porous metal prosthesis and a method of making the same
US20050283229A1 (en) * 1997-04-15 2005-12-22 Steve Dugan Coatings for controlling erosion of a substrate of an implantable medical device
US20050209680A1 (en) * 1997-04-15 2005-09-22 Gale David C Polymer and metal composite implantable medical devices
US8007529B2 (en) 1997-04-15 2011-08-30 Advanced Cardiovascular Systems, Inc. Medicated porous metal prosthesis
US8172897B2 (en) 1997-04-15 2012-05-08 Advanced Cardiovascular Systems, Inc. Polymer and metal composite implantable medical devices
US20040186553A1 (en) * 1997-04-15 2004-09-23 Yan John Y. Medicated porous metal prosthesis and a method of making the same
US20030093144A1 (en) * 1998-02-02 2003-05-15 Scimed Life Systems, Inc. Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal-connectors
US8562665B2 (en) 1998-02-02 2013-10-22 Boston Scientific Scimed, Inc. Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal-connectors
US8439968B2 (en) 1998-03-30 2013-05-14 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
US20040254635A1 (en) * 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US8361537B2 (en) 1998-03-30 2013-01-29 Innovational Holdings, Llc Expandable medical device with beneficial agent concentration gradient
US20040236408A1 (en) * 1998-03-30 2004-11-25 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20050203608A1 (en) * 1998-03-30 2005-09-15 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20040225350A1 (en) * 1998-03-30 2004-11-11 Shanley John F. Expandable medical device for delivery of beneficial agent
US8206435B2 (en) 1998-03-30 2012-06-26 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7819912B2 (en) 1998-03-30 2010-10-26 Innovational Holdings Llc Expandable medical device with beneficial agent delivery mechanism
US20080249609A1 (en) * 1998-03-30 2008-10-09 Shanley John F Expandable medical device with ductile hinges
US8623068B2 (en) 1998-03-30 2014-01-07 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7896912B2 (en) 1998-03-30 2011-03-01 Innovational Holdings, Llc Expandable medical device with S-shaped bridging elements
US20080243070A1 (en) * 1998-03-30 2008-10-02 Shanley John F Expandable medical device with beneficial agent delivery mechanism
US20030199970A1 (en) * 1998-03-30 2003-10-23 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20030167085A1 (en) * 1998-03-30 2003-09-04 Conor Medsystems, Inc. Expandable medical device with beneficial agent delivery mechanism
US20080294242A1 (en) * 1998-03-30 2008-11-27 Shanley John F Expandable medical device with ductile hinges
US7909865B2 (en) 1998-03-30 2011-03-22 Conor Medsystems, LLC Expandable medical device for delivery of beneficial agent
US7279004B2 (en) 1998-03-30 2007-10-09 Innovational Holdings, Llc. Expandable medical device with curved hinge
US20030009214A1 (en) * 1998-03-30 2003-01-09 Shanley John F. Medical device with beneficial agent delivery mechanism
US7179289B2 (en) 1998-03-30 2007-02-20 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20090163995A1 (en) * 1998-03-30 2009-06-25 Shanley John F Expandable medical device for delivery of beneficial agent
US7160321B2 (en) 1998-03-30 2007-01-09 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US8052734B2 (en) 1998-03-30 2011-11-08 Innovational Holdings, Llc Expandable medical device with beneficial agent delivery mechanism
US20080097581A1 (en) * 1998-03-30 2008-04-24 Shanley John F Expandable medical device with beneficial agent concentration gradient
US8052735B2 (en) 1998-03-30 2011-11-08 Innovational Holdings, Llc Expandable medical device with ductile hinges
US20110008529A1 (en) * 1999-09-03 2011-01-13 Advanced Cardiovascular Systems, Inc. Thermal Treatment Of An Implantable Medical Device
US8586125B2 (en) 1999-09-03 2013-11-19 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US20060129231A1 (en) * 2000-03-06 2006-06-15 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US8663317B2 (en) 2000-03-06 2014-03-04 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US7789907B2 (en) * 2000-03-06 2010-09-07 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US8267991B2 (en) 2000-03-06 2012-09-18 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US20020018795A1 (en) * 2000-04-13 2002-02-14 Whitbourne Richard J. Targeted therapeutic agent release devices and methods of making and using the same
US8101200B2 (en) 2000-04-13 2012-01-24 Angiotech Biocoatings, Inc. Targeted therapeutic agent release devices and methods of making and using the same
US7766956B2 (en) 2000-09-22 2010-08-03 Boston Scientific Scimed, Inc. Intravascular stent and assembly
US20040133271A1 (en) * 2000-09-22 2004-07-08 Jang G. David Intravascular stent and assembly
US6805898B1 (en) * 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
US6764507B2 (en) * 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
US20040220661A1 (en) * 2000-10-16 2004-11-04 Conor Medsystems, Inc. Expandable medial device with improved spatial distribution
US7850728B2 (en) 2000-10-16 2010-12-14 Innovational Holdings Llc Expandable medical device for delivery of beneficial agent
US8202313B2 (en) 2000-10-16 2012-06-19 Innovational Holdings Llc Expandable medical device with beneficial agent in openings
US8187321B2 (en) 2000-10-16 2012-05-29 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
US6979347B1 (en) * 2000-10-23 2005-12-27 Advanced Cardiovascular Systems, Inc. Implantable drug delivery prosthesis
US7060093B2 (en) 2000-10-30 2006-06-13 Advanced Cardiovascular Systems, Inc. Increased drug-loading and reduced stress drug delivery device
US20040220662A1 (en) * 2000-10-30 2004-11-04 Dang Kenny L. Increased drug-loading and reduced stress drug delivery device
US20040220660A1 (en) * 2001-02-05 2004-11-04 Shanley John F. Bioresorbable stent with beneficial agent reservoirs
US20020107563A1 (en) * 2001-02-05 2002-08-08 Shanley John F. Expandable medical device with locking mechanism
US20020121497A1 (en) * 2001-03-01 2002-09-05 Tomonto Charles V. Flexible stent and method of manufacture
US6998060B2 (en) * 2001-03-01 2006-02-14 Cordis Corporation Flexible stent and method of manufacture
US20040172124A1 (en) * 2001-07-20 2004-09-02 Sorin Biomedica Cardio S.P.A. Angioplasty stents
US7344563B2 (en) * 2001-07-20 2008-03-18 Sorin Biomedica Cardio S.R.L. Angioplasty stents
US20030068355A1 (en) * 2001-08-20 2003-04-10 Shanley John F. Therapeutic agent delivery device with protective separating layer
EP2108343A1 (en) * 2001-08-20 2009-10-14 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7850727B2 (en) 2001-08-20 2010-12-14 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
EP1666004A3 (en) * 2001-08-20 2008-07-09 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
WO2003015664A1 (en) * 2001-08-20 2003-02-27 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20060064157A1 (en) * 2001-08-20 2006-03-23 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20040249443A1 (en) * 2001-08-20 2004-12-09 Shanley John F. Expandable medical device for treating cardiac arrhythmias
EP1772122A3 (en) * 2001-08-20 2008-07-09 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20050058684A1 (en) * 2001-08-20 2005-03-17 Shanley John F. Therapeutic agent delivery device with controlled therapeutic agent release rates
EP1477137A3 (en) * 2001-08-20 2005-01-19 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
EP1666004A2 (en) * 2001-08-20 2006-06-07 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7658758B2 (en) 2001-09-07 2010-02-09 Innovational Holdings, Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20070082120A1 (en) * 2001-09-07 2007-04-12 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US8349390B2 (en) 2002-09-20 2013-01-08 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20060122697A1 (en) * 2002-09-20 2006-06-08 Conor Medsystems, Inc. Expandable medical device with openings for delivery of multiple beneficial agents
US20040127976A1 (en) * 2002-09-20 2004-07-01 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US7758636B2 (en) 2002-09-20 2010-07-20 Innovational Holdings Llc Expandable medical device with openings for delivery of multiple beneficial agents
US9254202B2 (en) 2002-09-20 2016-02-09 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20050234544A1 (en) * 2002-09-20 2005-10-20 Conor Medsystems, Inc. Expandable medical device with openings for delivery of multiple beneficial agents
US20060096660A1 (en) * 2002-09-20 2006-05-11 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20040073294A1 (en) * 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20070219628A1 (en) * 2002-09-23 2007-09-20 Innovational Holdings, Llc Implantable Medical Device with Drug Filled Holes
US7135038B1 (en) 2002-09-30 2006-11-14 Advanced Cardiovascular Systems, Inc. Drug eluting stent
US20110262621A1 (en) * 2002-11-07 2011-10-27 Abbott Laboratores Method of loading beneficial agent on a prosthesis
US20040143321A1 (en) * 2002-11-08 2004-07-22 Conor Medsystems, Inc. Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
US20060178735A1 (en) * 2002-11-08 2006-08-10 Conor Medsystems, Inc. Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
US20040143322A1 (en) * 2002-11-08 2004-07-22 Conor Medsystems, Inc. Method and apparatus for treating vulnerable artherosclerotic plaque
US20060008503A1 (en) * 2003-03-28 2006-01-12 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
US20040193255A1 (en) * 2003-03-28 2004-09-30 Shanley John F. Therapeutic agent delivery device with controlled therapeutic agent release rates
US20040202692A1 (en) * 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device and method for in situ selective modulation of agent delivery
US8449901B2 (en) 2003-03-28 2013-05-28 Innovational Holdings, Llc Implantable medical device with beneficial agent concentration gradient
US20060147489A1 (en) * 2003-03-28 2006-07-06 Conor Medsystems, Inc. Implantable medical device with beneficial agent concentration gradient
US20040249449A1 (en) * 2003-06-05 2004-12-09 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery
US20050222676A1 (en) * 2003-09-22 2005-10-06 Shanley John F Method and apparatus for loading a beneficial agent into an expandable medical device
US20110048574A1 (en) * 2003-09-22 2011-03-03 Innovational Holdings, Llc. Method and apparatus for loading a beneficial agent into an expandable medical device
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US8197881B2 (en) 2003-09-22 2012-06-12 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20050100577A1 (en) * 2003-11-10 2005-05-12 Parker Theodore L. Expandable medical device with beneficial agent matrix formed by a multi solvent system
USRE45744E1 (en) 2003-12-01 2015-10-13 Abbott Cardiovascular Systems Inc. Temperature controlled crimping
US20050118344A1 (en) * 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US8052912B2 (en) 2003-12-01 2011-11-08 Advanced Cardiovascular Systems, Inc. Temperature controlled crimping
US20050010170A1 (en) * 2004-02-11 2005-01-13 Shanley John F Implantable medical device with beneficial agent concentration gradient
US20040204756A1 (en) * 2004-02-11 2004-10-14 Diaz Stephen Hunter Absorbent article with improved liquid acquisition capacity
US20050182390A1 (en) * 2004-02-13 2005-08-18 Conor Medsystems, Inc. Implantable drug delivery device including wire filaments
US20090149947A1 (en) * 2004-06-09 2009-06-11 J.A.C.C. Gmbh Implantable device for drug delivery and improved visibility
WO2005120393A3 (en) * 2004-06-09 2006-06-08 J A C C Gmbh Implantable device for drug delivery and improved visibility
EP1604697A1 (en) * 2004-06-09 2005-12-14 J.A.C.C. GmbH Implantable device
US20050287287A1 (en) * 2004-06-24 2005-12-29 Parker Theodore L Methods and systems for loading an implantable medical device with beneficial agent
US20070043423A1 (en) * 2005-08-10 2007-02-22 Med Institute Inc. Intraluminal device with a hollow structure
US7682388B2 (en) * 2007-01-30 2010-03-23 Medtronic Vascular, Inc. Stent with longitudinal groove
US7575593B2 (en) * 2007-01-30 2009-08-18 Medtronic Vascular, Inc. Implantable device with reservoirs for increased drug loading
US20080183270A1 (en) * 2007-01-30 2008-07-31 Medtronic Vascular, Inc. Stent With Longitudinal Groove
US20080183281A1 (en) * 2007-01-30 2008-07-31 Medtronic Vascular, Inc. Implantable Device With Reservoirs for Increased Drug Loading
US8900292B2 (en) * 2007-08-03 2014-12-02 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US20100145437A1 (en) * 2007-09-19 2010-06-10 Boston Scientific Scimed, Inc. Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
US20090076591A1 (en) * 2007-09-19 2009-03-19 Boston Scientific Scimed, Inc. Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
US7951193B2 (en) * 2008-07-23 2011-05-31 Boston Scientific Scimed, Inc. Drug-eluting stent
US20100023115A1 (en) * 2008-07-23 2010-01-28 Boston Scientific Scimed, Inc. Drug-eluting stent
US9168161B2 (en) 2009-02-02 2015-10-27 Cordis Corporation Flexible stent design
US20100217380A1 (en) * 2009-02-02 2010-08-26 Ryan Donovan Flexible stent design
US9095459B2 (en) 2009-09-30 2015-08-04 Terumo Kabushiki Kaisha Stent with drug coat layer including a gradual stepwise decrease portion
US9737423B2 (en) 2009-09-30 2017-08-22 Terumo Kabushiki Kaisha Stent with drug coat layer
US9155644B2 (en) 2010-08-02 2015-10-13 Cordis Corporation Flexible helical stent having intermediate structural feature
US8920489B2 (en) 2010-08-02 2014-12-30 Cordis Corporation Flexible stent having protruding hinges
US8961590B2 (en) 2010-08-02 2015-02-24 Cordis Corporation Flexible helical stent having different helical regions
US10231855B2 (en) 2010-08-02 2019-03-19 CARDINAL HEALTH SWITZERLAND 515 GmbH Flexible helical stent having intermediate non-helical region
US20150250772A1 (en) * 2011-08-25 2015-09-10 Boston Scientific Scimed, Inc. Medical Device with Crystalline Drug Coating
US9486340B2 (en) * 2013-03-14 2016-11-08 Medtronic Vascular, Inc. Method for manufacturing a stent and stent manufactured thereby
US20140277382A1 (en) * 2013-03-14 2014-09-18 Medtronic Vascular, Inc. Method for Manufacturing a Stent and Stent Manufactured Thereby
CN104287878A (en) * 2014-09-16 2015-01-21 李宝童 Blood intra-cavity support

Also Published As

Publication number Publication date
US6783543B2 (en) 2004-08-31
US20120085734A1 (en) 2012-04-12
US20040148012A9 (en) 2004-07-29
WO2002098326A1 (en) 2002-12-12
JP2004528928A (en) 2004-09-24
US20040093071A1 (en) 2004-05-13
EP1397091A1 (en) 2004-03-17
CA2449484A1 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
CA2374176C (en) Flexible stent
US7455688B2 (en) Ostial stent
US8007527B2 (en) Stent with dual support structure
DE69928915T2 (en) unit cell and expandable intraluminal stent
US6740114B2 (en) Flexible stent
US7105015B2 (en) Method and system for treating an ostium of a side-branch vessel
US5931867A (en) Radially expandable support device
AU2002228855B2 (en) Stent for treating in-stent restenosis
US8100963B2 (en) Biodegradable device
JP4746267B2 (en) Expandable medical device for conveying a beneficial agent
EP2289465B1 (en) Stent with tapered segments
AU730691B2 (en) Intravascular dilatation implant with a deflector
US7722661B2 (en) Stent
US7607208B2 (en) Method of making a medicated stent
EP2292183B1 (en) Helical balloon with stent
US8128687B2 (en) Drug-eluting stent with filament strands
US8257432B2 (en) Vascular bifurcation prosthesis with at least one frond
AU2001294634B2 (en) Expandable medical device for delivery of beneficial agent
DE60114576T2 (en) Intraluminal, perforated, radially expandable prosthesis for delivery of drugs
DE19916086B4 (en) The implantable prosthesis, particularly vascular prosthesis (stent)
US6273908B1 (en) Stents
US6558733B1 (en) Method for etching a micropatterned microdepot prosthesis
US5776183A (en) Expandable stent
US7470281B2 (en) Coated stent with crimpable coating
US6132460A (en) Stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JANG, G. DAVID;REEL/FRAME:013560/0176

Effective date: 20021115

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12